Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Are maternal antiplatelet antibodies a prothrombotic condition leading to miscarriage?
Alvin H. Schmaier
Alvin H. Schmaier
Published October 24, 2011
Citation Information: J Clin Invest. 2011;121(11):4241-4243. https://doi.org/10.1172/JCI60749.
View: Text | PDF
Commentary

Are maternal antiplatelet antibodies a prothrombotic condition leading to miscarriage?

  • Text
  • PDF
Abstract

Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is a condition characterized by thrombocytopenia in the newborn. If severe, the thrombocytopenia can lead to intracranial hemorrhage. FNAIT arises when maternal antibodies specific for platelet antigens, most commonly β3 integrin, cross the placenta and destroy fetal platelets. Surprisingly, few cases of FNAIT are associated with antibodies specific for the platelet antigen GPIbα, which is a common target in patients with immune thrombocytopenia. In this issue of the JCI, Li et al. have identified a potential reason for this — they find that in the majority of pregnant mice, anti-GPIbα antibodies enhance platelet activation and accelerate thrombus formation in the placenta and that this leads to miscarriage.

Authors

Alvin H. Schmaier

×

Figure 1

The effects of maternal alloimmune anti-β3 antibodies and anti-GPIbα antibodies in pregnancy.

Options: View larger image (or click on image) Download as PowerPoint
The effects of maternal alloimmune anti-β3 antibodies and anti-GPIbα ant...
Maternal alloimmune antiplatelet antibodies are most commonly directed to the HPA-1a epitope of β3 integrin and can cause FNAIT. This entity is most commonly associated with thrombocytopenia and, in severe cases, neonatal intracerebral hemorrhage. FNAIT associated with anti-GPIbα antibodies has been rarely recognized. In this issue of the JCI, Li et al. report that in mice with anti-GPIbα antibodies, a high percentage of pregnancies results in placental thrombosis due to increased thrombin formation and that this leads to miscarriage (12). In contrast, mouse anti-β3 antibodies were more commonly observed to produce thrombocytopenia and less commonly associated with placental thrombosis and miscarriage. This report suggests that FNAIT may be a cause of thrombosis in addition to hemorrhage and that some antiplatelet antibodies may induce miscarriage.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts